Kymera Therapeutics (KYMR) AI Analysis

KYMR$134.84-1.80 -1.32%
BiotechnologyLarge CapGrowth Stock
Compare
Market cap$11.51BEnterprise value$11.34BRevenue (TTM)$102.22MMarket positionTop 25%

Score

39
Bearish
Value
25
Quality
29
Growth
64

AI Score 45. Kymera Therapeutics, Inc. has a high price of $136.25 with a market cap of $11.63 billion, but it is currently unprofitable with a net profit margin of -3.42% and a price-to-earnings ratio of -37.53

Kymera Therapeutics (KYMR) AI Analysis

KYMR price $134.84 -1.80 -1.32%

Ticker
KYMR
Price
$134.84
Change
-1.80 -1.32%
Market cap
$11.51B
Dividend yield
0.00%
Beta
2.03
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
39
Value
25
Quality
29
Growth
64

Stocklytics score rationale: value 25, quality 29, growth 64.

AI Score 45. Kymera Therapeutics, Inc. has a high price of $136.25 with a market cap of $11.63 billion, but it is currently unprofitable with a net profit margin of -3.42% and a price-to-earnings ratio of -37.53

Insights · Forecast · Financials · Learn

Stocklytics home · Screener